IGFBP3 and Prader-Willi syndrome: While the association between IGFBP-3 and sleep-related breathing disorders (SRBDs) in PWS remains unexplored, our study indicates that the heightened levels of IGF-1 and IGFBP-3 resulting from rhGH treatment do not adversely affect SRBDs.